163 related articles for article (PubMed ID: 22583459)
1. Mapping from disease-specific measures to health-state utility values in individuals with migraine.
Gillard PJ; Devine B; Varon SF; Liu L; Sullivan SD
Value Health; 2012 May; 15(3):485-94. PubMed ID: 22583459
[TBL] [Abstract][Full Text] [Related]
2. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Utility in Migraine: Mapping the Migraine-Specific Questionnaire to the EQ-5D-5L.
Ahadi MS; Vahidpour N; Togha M; Daroudi R; Nadjafi-Semnani F; Mohammadshirazi Z; Akbari-Sari A; Ghorbani Z
Value Health Reg Issues; 2021 Sep; 25():57-63. PubMed ID: 33773328
[TBL] [Abstract][Full Text] [Related]
4. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
Kay S; Ferreira A
Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
[TBL] [Abstract][Full Text] [Related]
5. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
6. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.
Hernández Alava M; Wailoo AJ; Ara R
Value Health; 2012 May; 15(3):550-61. PubMed ID: 22583466
[TBL] [Abstract][Full Text] [Related]
7. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ
Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials.
Di Tanna GL; Porter JK; Lipton RB; Hatswell AJ; Sapra S; Villa G
Health Qual Life Outcomes; 2019 Nov; 17(1):171. PubMed ID: 31718662
[TBL] [Abstract][Full Text] [Related]
9. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
Lipton RB; Varon SF; Grosberg B; McAllister PJ; Freitag F; Aurora SK; Dodick DW; Silberstein SD; Diener HC; DeGryse RE; Nolan ME; Turkel CC
Neurology; 2011 Oct; 77(15):1465-72. PubMed ID: 21956721
[TBL] [Abstract][Full Text] [Related]
10. Mapping the FACT-P to the preference-based EQ-5D questionnaire in metastatic castration-resistant prostate cancer.
Skaltsa K; Longworth L; Ivanescu C; Phung D; Holmstrom S
Value Health; 2014 Mar; 17(2):238-44. PubMed ID: 24636382
[TBL] [Abstract][Full Text] [Related]
11. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
12. Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities.
Blome C; Beikert FC; Rustenbach SJ; Augustin M
Arch Dermatol Res; 2013 Apr; 305(3):197-204. PubMed ID: 23266843
[TBL] [Abstract][Full Text] [Related]
13. The relationship among mental health status (GHQ-12), health related quality of life (EQ-5D) and health-state utilities in a general population.
Serrano-Aguilar P; Ramallo-Fariña Y; Trujillo-Martín Mdel M; Muñoz-Navarro SR; Perestelo-Perez L; de las Cuevas-Castresana C
Epidemiol Psichiatr Soc; 2009; 18(3):229-39. PubMed ID: 20034201
[TBL] [Abstract][Full Text] [Related]
14. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
[TBL] [Abstract][Full Text] [Related]
15. Comparison of FACT- and EQ-5D-based utility scores in cancer.
Pickard AS; Ray S; Ganguli A; Cella D
Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
[TBL] [Abstract][Full Text] [Related]
16. Estimating EuroQol EQ-5D scores from Population Healthy Days data.
Jia H; Lubetkin EI
Med Decis Making; 2008; 28(4):491-9. PubMed ID: 18556640
[TBL] [Abstract][Full Text] [Related]
17. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
Lillegraven S; Kristiansen IS; Kvien TK
Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
[TBL] [Abstract][Full Text] [Related]
18. Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample.
Lawrence WF; Fleishman JA
Med Decis Making; 2004; 24(2):160-9. PubMed ID: 15090102
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Korean Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraine.
Seo JG; Park SP
J Oral Facial Pain Headache; 2017 Summer; 31(3):251-256. PubMed ID: 28738110
[TBL] [Abstract][Full Text] [Related]
20. Social valuation of EQ-5D health states: the Chilean case.
Zarate V; Kind P; Valenzuela P; Vignau A; Olivares-Tirado P; Munoz A
Value Health; 2011 Dec; 14(8):1135-41. PubMed ID: 22152184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]